Key Metrics of IceCure Medical Ltd.
Revenue$3.2M▲ 4.7% YoYFY 2023
Operating income−$15.6M▲ 6.9% YoY
Net profit−$14.7M▲ 13.7% YoY
Shareholders' equity$12.2M
Market cap$3.4MICCM · $1.00
Competitors10identified
About IceCure Medical Ltd.
Sectors
Company details
- Listed
- Nasdaq: ICCM
Operational Areas of IceCure Medical Ltd.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameIceCure Medical Ltd.
TickerICCM
ExchangeNasdaq
CountryIsrael
SEC CIK0001584371
Listed since—
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
ICCM · Nasdaq · SEC CIK 0001584371
Last price · 23 Oct 2026
$1.00
−7.41%
Market cap$3.4M
P/E3.1On FY 2023 diluted EPS
Volume168,568
SectorHealth CareMedical/Dental Instruments
Country · IPOIsrael
ICCM share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of IceCure Medical Ltd.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.